Ταυτότητα

Ravoxertinib

Δεν αναφέρεται · C21H18ClFN6O2

01Ταυτότητα

Lazychem IDLC-55620
CAS RNΔεν αναφέρεται
PubChem CID71727581
Molecular formulaC21H18ClFN6O2
Molecular weight440.9 g/mol
IUPAC name1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]pyridin-2-one
InChIKeyRZUOCXOYPYGSKL-GOSISDBHSA-N

02Δομή και στερεοχημεία

2D structurePubChem CID 71727581
Two-dimensional chemical structure of Ravoxertinib
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.
SMILESCN1C(=CC=N1)NC2=NC=CC(=N2)C3=CC(=O)N(C=C3)[C@H](CO)C4=CC(=C(C=C4)Cl)F
InChIΔεν αναφέρεται

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Κατάσταση στην Ινδία

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Ονόματα και σχέσεις

API και μητρικό φάρμακο

Δεν αναφέρεται

Ονόματα και σχέσεις

    Προσμίξεις και συγγενείς ενώσεις

      06Πηγές